IRCCS Istituo Clinico Humanitas
Rozzano, Milano, 20089, Italy
Location status: Recruiting
Location contact
Alessandra Cataldo, PhD
CONTACT
Antonio Mangieri, MD
CONTACT
NCT Number: NCT06508866
The TACTIC-TAVI registry aims to collect information about a consecutive cohort of patients undergoing transcatheter aortic valve insertion. The registry is international, multi-centre and observational. The registry is planned to continue until the calculated sample size is achieved.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Rozzano, Milano, 20089, Italy
Location status: Recruiting
Alessandra Cataldo, PhD
CONTACT
Antonio Mangieri, MD
CONTACT
All patients since February 2023 treated successfully with TAVI until the study endpoint will be deemed suitable for inclusion in the registry. The registry will:
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients successfully undergoing transcatheter aortic valve implantation for native severe aortic stenosis.
-
Exclusion criteria
Time frame: 0-24 months
The primary focus of the registry is evaluating which patient characteristics and conduction disturbances may help to predict the new requirement for permanent pacemaker after TAVI.
Contact information is provided by the study sponsor or research team.
Antonio Mangieri, MD
CONTACT
Ottavia Cozzi, MD
CONTACT
Istituto Clinico Humanitas
Other
Timing And Typology of ConducTIon disturbanCes During TAVI: the TACTIC-TAVI Registry
Acronym: TACTIC-TAVI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05172960
Aortic Stenosis, Severe, Aortic Valve Disease
La Jolla, California, United States
View Trial DetailsNCT06596460
Aortic Stenosis, Severe, Aortic Valve Disease
London, England, United Kingdom
View Trial DetailsNCT06377449
Aneurysm, Aneurysm, Ascending Aorta
Saint Petersburg, Sankt-Peterburg, Russia
View Trial DetailsNCT03003299
Aortic Stenosis, Aortic Stenosis, Severe
Phoenix, Arizona, United States
View Trial Details